H2AX and thyroid cancer: After molecular therapy (MRT) of differentiated thyroid cancer with the isotope I-131 there are only two studies that quantified DSB foci response, using either radiation-induced γ-H2AX and 53BP1 foci [23] or only γ-H2AX foci [24].